Logo image of ASPS

ALTISOURCE PORTFOLIO SOL (ASPS) Stock Fundamental Analysis

NASDAQ:ASPS - Nasdaq - LU0445408270 - Common Stock - Currency: USD

0.95  -0.07 (-6.86%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ASPS. ASPS was compared to 65 industry peers in the Real Estate Management & Development industry. ASPS may be in some trouble as it scores bad on both profitability and health. ASPS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ASPS has reported negative net income.
ASPS had a negative operating cash flow in the past year.
In the past 5 years ASPS reported 4 times negative net income.
In the past 5 years ASPS always reported negative operating cash flow.
ASPS Yearly Net Income VS EBIT VS OCF VS FCFASPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

The Return On Assets of ASPS (-24.82%) is worse than 78.46% of its industry peers.
Industry RankSector Rank
ROA -24.82%
ROE N/A
ROIC N/A
ROA(3y)-29.51%
ROA(5y)-21.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPS Yearly ROA, ROE, ROICASPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

The Operating Margin of ASPS (2.44%) is better than 64.62% of its industry peers.
ASPS's Operating Margin has improved in the last couple of years.
ASPS has a Gross Margin of 30.93%. This is comparable to the rest of the industry: ASPS outperforms 56.92% of its industry peers.
ASPS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.44%
PM (TTM) N/A
GM 30.93%
OM growth 3YN/A
OM growth 5Y1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y98.22%
GM growth 5Y5.24%
ASPS Yearly Profit, Operating, Gross MarginsASPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

ASPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASPS has more shares outstanding than it did 1 year ago.
ASPS has more shares outstanding than it did 5 years ago.
ASPS has a worse debt/assets ratio than last year.
ASPS Yearly Shares OutstandingASPS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ASPS Yearly Total Debt VS Total AssetsASPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ASPS has an Altman-Z score of -3.00. This is a bad value and indicates that ASPS is not financially healthy and even has some risk of bankruptcy.
ASPS's Altman-Z score of -3.00 is on the low side compared to the rest of the industry. ASPS is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3
ROIC/WACCN/A
WACC8.22%
ASPS Yearly LT Debt VS Equity VS FCFASPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.19 indicates that ASPS may have some problems paying its short term obligations.
ASPS has a worse Current ratio (0.19) than 86.15% of its industry peers.
A Quick Ratio of 0.19 indicates that ASPS may have some problems paying its short term obligations.
ASPS's Quick ratio of 0.19 is on the low side compared to the rest of the industry. ASPS is outperformed by 86.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
ASPS Yearly Current Assets VS Current LiabilitesASPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.80% over the past year.
Looking at the last year, ASPS shows a quite strong growth in Revenue. The Revenue has grown by 10.39% in the last year.
ASPS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -24.41% yearly.
EPS 1Y (TTM)63.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)10.39%
Revenue growth 3Y-3.55%
Revenue growth 5Y-24.41%
Sales Q2Q%3.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y62.99%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASPS Yearly Revenue VS EstimatesASPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ASPS Yearly EPS VS EstimatesASPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ASPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ASPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPS Price Earnings VS Forward Price EarningsASPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASPS is valued a bit cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.64
ASPS Per share dataASPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTISOURCE PORTFOLIO SOL

NASDAQ:ASPS (5/2/2025, 8:00:01 PM)

0.95

-0.07 (-6.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-21 2025-07-21
Inst Owners33.86%
Inst Owner Change0%
Ins Owners27.32%
Ins Owner Change47.14%
Market Cap83.20M
Analysts43.33
Price Target10.2 (973.68%)
Short Float %1.53%
Short Ratio9.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.65%
Min EPS beat(2)-34.8%
Max EPS beat(2)48.1%
EPS beat(4)2
Avg EPS beat(4)3.57%
Min EPS beat(4)-34.8%
Max EPS beat(4)48.1%
EPS beat(8)4
Avg EPS beat(8)-1.79%
EPS beat(12)6
Avg EPS beat(12)-0.77%
EPS beat(16)6
Avg EPS beat(16)-17.63%
Revenue beat(2)0
Avg Revenue beat(2)-29.5%
Min Revenue beat(2)-46.46%
Max Revenue beat(2)-12.54%
Revenue beat(4)1
Avg Revenue beat(4)-12.74%
Min Revenue beat(4)-46.46%
Max Revenue beat(4)10.63%
Revenue beat(8)2
Avg Revenue beat(8)-7.88%
Revenue beat(12)4
Avg Revenue beat(12)-6.03%
Revenue beat(16)5
Avg Revenue beat(16)-7.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 24.64
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.83
BVpS-1.8
TBVpS-2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.82%
ROE N/A
ROCE -3.06%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 2.44%
PM (TTM) N/A
GM 30.93%
FCFM N/A
ROA(3y)-29.51%
ROA(5y)-21.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y98.22%
GM growth 5Y5.24%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.09
Cap/Depr 0.04%
Cap/Sales 0%
Interest Coverage 0.16
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -3
F-Score6
WACC8.22%
ROIC/WACCN/A
Cap/Depr(3y)2.56%
Cap/Depr(5y)5.32%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y62.99%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.39%
Revenue growth 3Y-3.55%
Revenue growth 5Y-24.41%
Sales Q2Q%3.63%
Revenue Next Year33.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y123.31%
EBIT growth 3YN/A
EBIT growth 5Y-22.96%
EBIT Next Year468.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.98%
OCF growth 3YN/A
OCF growth 5YN/A